Valuation: DEEPVERGE

Market Cap 8.75M 7.85M 7.25M 6.57M 12.28M 831M 12.43M 86.89M 34.51M 435M 32.83M 32.12M 1.38B P/E 2020
-12.5x
P/E 2021 -19.3x
Enterprise Value 9.18M 8.24M 7.61M 6.9M 12.89M 872M 13.05M 91.2M 36.22M 457M 34.46M 33.72M 1.45B EV / Sales 2020
10x
EV / Sales 2021 6.11x
Free-Float
90.54%
Yield 2020 *
-
Yield 2021 -
5 years 0
Extreme 0.0005
0.34
10 years 0
Extreme 0.0005
0.42
Manager TitleAgeSince
Chief Executive Officer 68 01/11/2022
Director of Finance/CFO - 30/08/2018
Sales & Marketing 53 12/07/2021
Director TitleAgeSince
Chairman 66 21/05/2019
Director/Board Member 68 10/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
16/11/22 Free

Executive/Senior Manager

162,500 0.0740%
16/11/22 Buy

Chief Financial Officer

2,000,000 0.9103%
16/11/22 Buy

Executive/Senior Manager

650,000 0.2958%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-.--% 421K
-0.16%-1.39%+15.94%+72.55% 738B
-0.47%-2.83%+12.66%+70.19% 85.29B
+0.95%+9.93%+34.20%+185.95% 71.95B
-0.42%-2.45%-23.58%+9.30% 46.95B
-0.09%-3.87%-6.23%+91.70% 45.26B
+0.96%+0.15%+41.04%+759.15% 46.73B
+0.62%+4.70%+19.16%+43.66% 33.54B
-0.99%-2.70%+38.86%+78.19% 26.07B
-0.06%-1.63%-62.41%-58.01% 25.21B
Average +0.06%+0.43%+6.96%+125.27% 111.86B
Weighted average by Cap. +0.03%-0.30%+14.22%+102.79%

Financials

2020 2021
Net sales 4.48M 4.02M 3.72M 3.37M 6.3M 426M 6.37M 44.54M 17.69M 223M 16.83M 16.47M 708M 9.3M 8.34M 7.7M 6.99M 13.06M 883M 13.22M 92.37M 36.69M 463M 34.9M 34.15M 1.47B
Net income -2.72M -2.44M -2.25M -2.04M -3.82M -258M -3.86M -27.01M -10.72M -135M -10.2M -9.98M -429M -2.68M -2.4M -2.22M -2.01M -3.76M -254M -3.81M -26.62M -10.57M -133M -10.06M -9.84M -423M
Net Debt 1.11M 999K 922K 836K 1.56M 106M 1.58M 11.06M 4.39M 55.41M 4.18M 4.09M 176M 434K 390K 360K 326K 610K 41.22M 617K 4.31M 1.71M 21.61M 1.63M 1.59M 68.52M
Logo DEEPVERGE
Deepverge PLC is an Ireland-based vertically integrated company. The Company provides core skin and human testing technology. The Company is engaged in collaborating technology platforms with partners in artificial intelligence (AI), clinical research, medical device, life science and environmental science. Its Labskin delivers human skin microbiology services to support product R&D activities in the cosmetic, personal care, medical device and pharmaceutical sectors. The Labskin model is a 3D human skin equivalent that incorporates vital biological components to model normal skin function. It allows skin-care, health-care, nutritional, pharmaceutical manufacturers and cosmetic companies to test consumer products on human-like skin in a real-world environment with full access to multiple partner technologies.
Employees
73